
Ibc Pharmaceuticals Private Limited
About Ibc Pharmaceuticals Private Limited
Data last updated:
Ibc Pharmaceuticals Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the specialty chemicals segment of the chemicals and materials sector. It was incorporated on 05 April 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24239MH2011PTC215791. Its GSTIN is 27AACCI5767R1ZP (Maharashtra). The company holds 4 GST registrations, of which 2 are active.
The company has an authorised share capital of ₹11 Lakh and a paid-up capital of ₹4.48 Lakh. It is led by directors including Deepak Virbhadra Kabbur and Kranthikiran Siddappa.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Thane, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹94 Lakh, a growth of 37% compared to the previous year. For the same year it recorded a net profit of ₹16,042 (net margin 0.2%) and EBITDA of ₹10.48 Lakh (EBITDA margin 11.2%). Revenue has grown at a compounded annual rate (CAGR) of 112% over three years and 20% over five years.
As per MCA filings, the company has open charges of ₹2 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Ibc Pharmaceuticals Private Limited's registered office is in Thane, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressOffice No 705 And 706 Arihant Aura, Plot No.13/1 Ttc Industrial Area Turbhe, Thane, Maharashtra, India – 400705
- IndustryChemicals and Materials, Specialty Chemicals
To see the full contact details of Ibc Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Ibc Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale and retail trade and repair of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 45 | Wholesale and retail trade and repair of motor vehicles and motorcycles |
To see the full business activity and turnover split of Ibc Pharmaceuticals Private Limited, buy the company report.
Financials of Ibc Pharmaceuticals Private Limited
FY 2025 filings availableIbc Pharmaceuticals Private Limited reported revenue of ₹94 Lakh (up 37% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 20% over five years, including 37% growth in the latest year. EBITDA fell 34% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹10.48 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹16,042 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 11.2% | ||||
| Net Profit Margin | 0.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Ibc Pharmaceuticals Private Limited, buy the company report.
Board of directors of Ibc Pharmaceuticals Private Limited
Ibc Pharmaceuticals has 5 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Deepak Virbhadra Kabbur Also directs: Brio Pharma Technologies Private Limited, Brio Packaging Private Limited, Promedica Pharmaceuticals Private Limited and 1 more | Director | 29 Nov 2017 | 8 Years 11 Months | Current |
| Kranthikiran Siddappa | Director | 29 Nov 2017 | 8 Years 11 Months | Current |
| Ravindranath Tagore Talasila Also directs: Promedica Pharmaceuticals Private Limited | Director | 29 Nov 2017 | 8 Years 11 Months | Current |
| Rajeev Virbhadra Kabbur | Director | 14 Feb 2020 | 6 Years 9 Months | Current |
| Shubham Suresh Mishra Also directs: S2 Genesis LLP, Petals Packtech Private Limited, Brio Engineering Private Limited and 4 more | Director | 05 Apr 2011 | 15 Years 7 Months | Current |
Auditor
Ibc Pharmaceuticals Private Limited is audited by AKASAM & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| AKASAM & ASSOCIATES | FY 2023 | 005832S |
Shareholding
The shareholding of Ibc Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Ibc Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 14 Nov 2024 | 101026770 | State Bank of India | ₹2 Cr | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Ibc Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ibc Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Ibc Pharmaceuticals has 4 GST registrations: 2 active and 2 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AACCI5767R1ZP | Maharashtra | Active | 01 Jul 2017 |
| 36AACCI5767R2ZP | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Ibc Pharmaceuticals Private Limited, buy the company report.
Recent activity
Ibc Pharmaceuticals Private Limited has 11 board changes on record since 2011: 5 appointments and 6 cessations. The latest: Rajeev Virbhadra Kabbur ceased to be Additional Director on 31 Dec 2020.
3 earlier events are in the company report.
Frequently asked questions
Ibc Pharmaceuticals is an active private limited company based in Thane, Maharashtra, India. The company works in specialty chemicals, within the chemicals and materials industry. It was incorporated on 05 April 2011 (15+ years old) and is registered under CIN U24239MH2011PTC215791.
Ibc Pharmaceuticals has 5 current directors:
- Deepak Virbhadra Kabbur - Director
- Kranthikiran Siddappa - Director
- Ravindranath Tagore Talasila - Director
- Rajeev Virbhadra Kabbur - Director
- Shubham Suresh Mishra - Director
The latest financial statements of Ibc Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Ibc Pharmaceuticals is 27AACCI5767R1ZP, registered in Maharashtra. The company has 4 GST registrations in all, of which 2 are active and 2 are cancelled or inactive. Other active GSTINs include 36AACCI5767R2ZP (Telangana).
The CIN (Corporate Identification Number) of Ibc Pharmaceuticals is U24239MH2011PTC215791. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ibc Pharmaceuticals was incorporated on 05 April 2011, making it 15+ years old. It is registered with the Registrar of Companies, Mumbai.
Rajeev Virbhadra Kabbur ceased to be Additional Director on 31 Dec 2020. Rajeev Virbhadra Kabbur was appointed as Director on 14 Feb 2020. Deepak Virbhadra Kabbur ceased to be Additional Director on 30 Sep 2019. Ibc Pharmaceuticals has 11 board changes on record in total.
The registered office of Ibc Pharmaceuticals is at Office No 705 And 706 Arihant Aura, Plot No.131 Ttc Industrial Area Turbhe, Thane, Maharashtra, India – 400705.
Ibc Pharmaceuticals operates in the chemicals and materials industry, in the specialty chemicals segment.
Ibc Pharmaceuticals has open charges of ₹2 Cr and no satisfied charges on record as per latest MCA filings.

